Acarbose With Comparable Glucose-Lowering but Superior Weight-Loss Efficacy to Dipeptidyl Peptidase-4 Inhibitors: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
Conclusions: Acarbose and DPP-4is have similar glucose-lowering effects, but the weight-loss effects of acarbose are superior. Therefore, in the use of the most optimal dosages, overweight/obese type 2 diabetics might benefit more from a treatment with acarbose than DPP-4is.
Source: Frontiers in Endocrinology - Category: Endocrinology Source Type: research
More News: Acarbose | China Health | Conferences | Databases & Libraries | Diabetes | Diabetes Type 2 | Eating Disorders & Weight Management | Endocrinology | Gastroenterology | Obesity | Science | Study | Weight Loss